Similar biological activity in skin prick test for Oralair® (8200 BAU) and Grazax® (6200 BAU) reinforces effective SLIT dosing level
- 12 September 2016
- Vol. 71 (12) , 1782-1786
Abstract
In Europe, allergen extracts are standardized based on skin prick wheal size in 20–30 allergic subjects. To understand the biological activity of clinically effective Sublingual immunotherapy, we used this method to determine the biological activity of solution and tablet Timothy grass pollen (TIM) extracts, compared to an FDA‐approved extract (Reference) of 10 000 BAU/ml. Blinded, quadruplicate skin prick tests with concentrate and three serial half‐log dilutions allowed the construction of a semilogarithmic regression line per extract. Bioequivalent allergy units (BAU) values were obtained from the comparison with reference. Extracts and dilutions showed a neat linear dose response (all: R2 > 0.98) in 33 rhinitis patients. Relative potencies: Staloral® 12 000 BAU/ml, Soluprick® 10 300 BAU/ml, Oralair® 8200 BAU, and Grazax® 6200 BAU. Even though all extract concentrates differed in wheal size (P = 0.01–0.001), Grazax® producing a 25% smaller wheal size than Oralair®, and the biological activity of these clinically effective TIM tablets led in the same range (6200–8200 BAU; 0.92–1.23 cm2). SLIT dose‐finding studies for other pollens might start with allergen extracts producing 1.1 cm2 wheal surface.Keywords
Funding Information
- World Allergy Organization and the American College of Allergy, Asthma and Immunology
This publication has 19 references indexed in Scilit:
- Variation in allergen content in sublingual allergen immunotherapy with house dust mitesAllergy, 2015
- Post‐treatment efficacy of discontinuous treatment with 300IR 5‐grass pollen sublingual tablet in adults with grass pollen‐induced allergic rhinoconjunctivitisClinical & Experimental Allergy, 2013
- SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trialJournal of Allergy and Clinical Immunology, 2012
- Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy unitsAnnals of Allergy, Asthma & Immunology, 2011
- European and Mexican vs US diagnostic extracts of Bermuda grass and cat in skin testingAnnals of Allergy, Asthma & Immunology, 2011
- Allergen immunotherapy: A practice parameter third updateJournal of Allergy and Clinical Immunology, 2011
- Skin prick test evaluation of Dermatophagoides pteronyssinus diagnostic extracts from Europe, Mexico, and the United StatesAnnals of Allergy, Asthma & Immunology, 2010
- Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapyAllergy, 2009
- European allergen extract units and potency: review of available informationAnnals of Allergy, Asthma & Immunology, 2008
- Skin testingAnnals of Allergy, Asthma & Immunology, 2006